Literature DB >> 1109723

Prevalence and significance of hepatitis B surface antigen in a general hospital.

S V Feinman, O Krassnitzky, J C Sinclair, D M Wrobel, B Berris.   

Abstract

Over a 6-month period 2025 patients admitted to New Mount Sinai Hospital, Toronto were screened for hepatitis B surface antigen (HBsAg) by counter-immunoelectrophoresis (CIEP) and radioimmunoassay (RIA). CIEP detected 12 HBsAg-positive patients and RIA 16. RIA is therefore the more sensitive test for HBsAg. Of the 16 patients 2 had liver disease previously diagnosed, 3 had malignant disease and 11 were asymptomatic carriers. Of the 11 carriers all were born in countries where the carrier rate is known to be high. Routine screening of hospital patients on admission is of no value in detecting unsuspected liver disease but is of value in detecting asymptomatic carriers, which is of importance for the patient and his family. Routine screening tests for HBsAg in Canadian hospitals that treat many patients born in countries with a known high HBsAg prevalence is recommended. Routine screening is also recommended in all hospitals in Mediterranean and Asian countries.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1109723      PMCID: PMC1956002     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  Viral hepatitis. A staff hazard in dialysis units.

Authors:  P O Jones; H J Goldsmith; F K Wright; C Roberts; D C Watson
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

2.  Hepatitis-B antigen in saliva and semen.

Authors:  J Heathcote; C H Cameron; D S Dane
Journal:  Lancet       Date:  1974-01-19       Impact factor: 79.321

3.  A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel.

Authors:  T L Lewis; H J Alter; T C Chalmers; P V Holland; R H Purcell; D W Alling; D Young; L D Frenkel; S L Lee; M E Lamson
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Hepatitis B antigen (HBAg) and its antibody (HBAb) in hospital patients.

Authors:  R W Payne; A Barr; J Wallace
Journal:  J Clin Pathol       Date:  1974-02       Impact factor: 3.411

5.  Viral hepatitis: an occupational hazard to surgeons.

Authors:  J L Rosenberg; D P Jones; L R Lipitz; J B Kirsner
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

6.  Au-SH-antigen in liver disease.

Authors:  F Wewalka; F Gnan; O Krassnitzky; F Pesendorfer
Journal:  Vox Sang       Date:  1970 Sep-Oct       Impact factor: 2.144

7.  The Ausria test: critical evaluation of sensitivity and specificity.

Authors:  H J Alter; P V Holland; R H Purcell; J L Gerin
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

8.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

Authors:  H J Alter; P V Holland; R H Purcell; J J Lander; S M Feinstone; A G Morrow; P J Schmidt
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

10.  Frequency of hepatitis B antigen in blood donors.

Authors:  D M Wrobel; V Feinman; B Berris; J Sinclair
Journal:  Can Med Assoc J       Date:  1973-03-03       Impact factor: 8.262

View more
  4 in total

1.  Feasibility of routine testing for hepatitis B surface antigen in hospital employees and restriction of carriers.

Authors:  W D Leers; G M Kouroupis; A Dong
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

2.  Prevalence of hepatitis B surface antibodies in ethnic groups of a Canadian hospital staff population.

Authors:  W D Leers
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Viral hepatitis: new aspects of an old disease.

Authors:  S V Feinman
Journal:  Can Fam Physician       Date:  1976-08       Impact factor: 3.275

4.  Prevalence of bloodborne infective agents among people admitted to a Canadian hospital.

Authors:  M Louie; D E Low; S V Feinman; B McLaughlin; A E Simor
Journal:  CMAJ       Date:  1992-04-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.